Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_37838 | 40 | 0.83 | Mlig455_012885 | Neo: - Age: Up-Down-Down |
PKDREJ | Mlig455_012885 {REF} {Length: 13341} {Pfam: Polycystin cation channel [PF08016.14, score=221.2]; REJ domain [PF02010.17, score=52.8]; PLAT/LH2 domain [PF01477.25, score=27.5]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=184, Expect=7e-46]} {Mouse: ENSMUSG00000052496, Pkdrej, polycystin (PKD) family receptor for egg jelly, [Score=186, Expect=7e-47]; ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=178, Expect=3e-44]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=110, Expect=6e-24]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=121, Expect=3e-27]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=260, Expect=1e-69]} {RNA1509_38015} {RNA1310_23208, RNA1509_38015} {RNA1509_38015, RNA815_31966} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.083 | 1.174 | 0.99943 | 1.00000 | |
RegionR2 | 3.83 | 1.174 | 0.47973 | 0.86393 | |
RegionR3 | 2.245 | 1.174 | 0.31290 | 0.85248 | |
RegionR4 | 3.457 | 1.174 | 0.17307 | 0.43803 | |
RegionR5 | -1.363 | 1.174 | 1.00000 | 1.00000 | |
RegionR6 | -1.876 | 1.174 | 0.99932 | 1.00000 | |
RegionR7 | -2.142 | 1.174 | 1.00000 | 1.00000 | |
RegionR8 | -2.068 | 1.174 | 0.99941 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.306 | 1.174 | 0.99975 | 1.00000 | |
RegenerationR2 | -0.686 | 1.174 | 0.86162 | 1.00000 | |
RegenerationR3 | -1.434 | 1.174 | 0.73678 | 0.95954 | |
RegenerationR4 | -3.506 | 1.174 | 0.33946 | 0.77117 | |
RegenerationR5 | 0.804 | 1.174 | 0.52311 | 0.87106 | |
RegenerationR6 | -0.637 | 1.174 | 0.99974 | 1.00000 | |
RegenerationBL | 3.772 | 1.174 | 0.20741 | 0.54962 | |
RegenerationTP | -0.539 | 1.174 | 0.99960 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_37838 | 40 | 0.83 | Mlig455_012885 | Neo: - Age: Up-Down-Down |
PKDREJ | 5 | 1.000 | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_012885 {REF} {Length: 13341} {Pfam: Polycystin cation channel [PF08016.14, score=221.2]; REJ domain [PF02010.17, score=52.8]; PLAT/LH2 domain [PF01477.25, score=27.5]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=184, Expect=7e-46]} {Mouse: ENSMUSG00000052496, Pkdrej, polycystin (PKD) family receptor for egg jelly, [Score=186, Expect=7e-47]; ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=178, Expect=3e-44]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=110, Expect=6e-24]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=121, Expect=3e-27]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=260, Expect=1e-69]} {RNA1509_38015} {RNA1310_23208, RNA1509_38015} {RNA1509_38015, RNA815_31966} |
2. | MligTC455_11701 | 54 | 1.12 | Mlig455_042837, Mlig455_045855, Mlig455_045871 | Neo: - Age: - |
4.334 | 0.977 | - | 0.883 | 0.990 | 0.764 | 0.720 | Mlig455_042837 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045855 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045871 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} |
|
3. | MligTC455_45020 | 386 | 8.05 | Mlig455_012422 | Neo: - Age: - Region-enriched R2: 4.067/0.00066 |
AVP | 3.897 | 0.792 | - | 0.707 | 0.974 | 0.700 | 0.724 | Mlig455_012422 {REF} {Length: 1252} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.0]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=50.4, Expect=4e-08]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=52.0, Expect=7e-09]} {RNA1509_50574} {RNA1310_26737, RNA1509_50574} {RNA1509_50574, RNA815_23813} |
4. | MligTC455_42484 | 246 | 5.12 | Mlig455_046416 | Neo: - Age: Down-Up-Down Region-specific R2: 4.313 Region-enriched R2: 2.983/0.00930 |
3.532 | 0.973 | - | - | 0.983 | 0.732 | 0.844 | Mlig455_046416 {REF} {Length: 1006} {RNA1310_40237.1} {RNA815_18246} | |
5. | MligTC455_17218 | 37 | 0.78 | Mlig455_053853 | Neo: - Age: - |
3.514 | 0.982 | - | 0.814 | 0.998 | - | 0.720 | Mlig455_053853 {REF} {Length: 1743} {RNA1310_61921} | |
6. | MligTC455_44713 | 661 | 13.77 | Mlig455_048154 | Neo: - Age: logFC(26M/2M)=0.569 Region-specific R2: 3.883 Region-enriched R2: 3.422/0.00000 |
3.468 | 0.963 | - | - | 0.938 | 0.747 | 0.820 | Mlig455_048154 {REF} {Length: 1173} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
7. | MligTC455_46155 | 116 | 2.42 | Mlig455_027239 | Neo: - Age: - Region-enriched R2: 4.163/0.03818 |
GRK3 | 3.378 | 0.969 | - | - | 0.868 | 0.729 | 0.812 | Mlig455_027239 {REF} {Length: 2919} {Pfam: Protein kinase domain [PF00069.27, score=226.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=100.5]; Regulator of G protein signaling domain [PF00615.21, score=48.3]} {Human: ENSG00000100077, GRK3, G protein-coupled receptor kinase 3, [Score=845, Expect=0.0]; ENSG00000173020, GRK2, G protein-coupled receptor kinase 2, [Score=838, Expect=0.0]} {Mouse: ENSMUSG00000042249, Grk3, G protein-coupled receptor kinase 3, [Score=838, Expect=0.0]; ENSMUSG00000024858, Grk2, G protein-coupled receptor kinase 2, [Score=838, Expect=0.0]} {Dmel: FBgn0260798, Gprk1, G protein-coupled receptor kinase 1, [Score=842, Expect=0.0]} {Celegans: WBGene00001709, grk-2, G protein-coupled receptor kinase 2, [Score=819, Expect=0.0]} {Smed: dd_Smed_v6_6480_0_1, dd_Smed_v6_6480_0_1, [Score=949, Expect=0.0]} {RNA1509_7002} {RNA1310_16658} {RNA815_28070} |
8. | MligTC455_24406 | 204 | 4.25 | Mlig455_043947 | Neo: - Age: - Region-specific R2: 3.852 Region-enriched R2: 3.953/0.00003 |
3.361 | 0.936 | - | 0.706 | 0.974 | 0.745 | - | Mlig455_043947 {REF} {Length: 1609} {RNA1509_54091} {RNA1310_68348.1, RNA1509_54091} {RNA1509_54091, RNA815_33570.1} | |
9. | MligTC455_39988 | 83 | 1.73 | Mlig455_062081 | Neo: - Age: - |
3.36 | 0.991 | - | - | 0.843 | 0.811 | 0.715 | Mlig455_062081 {REF} {Length: 447} {NoTransDecoderORF} {RNA1509_50426} {RNA1310_88257} {RNA815_17173.4} | |
10. | MligTC455_45487 | 110 | 2.3 | Mlig455_004129, Mlig455_060457 | Neo: - Age: - |
3.348 | 0.977 | - | - | 0.939 | 0.717 | 0.715 | Mlig455_004129 {REF} {Length: 1131} {Pfam: PAN domain [PF00024.28, score=18.8]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=64.3, Expect=2e-12]} {RNA1310_37660} {RNA815_17816.1} Mlig455_060457 {REF} {Length: 1507} {Pfam: PAN domain [PF00024.28, score=19.5]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=64.3, Expect=2e-12]} {RNA1509_54623} {RNA1310_33480} {RNA815_17816.1} |
|
11. | MligTC455_49957 | 119 | 2.47 | Mlig455_005610, Mlig455_014448 | Neo: - Age: - |
3.345 | 0.944 | - | - | 0.950 | 0.747 | 0.704 | Mlig455_005610 {REF} {Length: 1455} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=66.2, Expect=4e-13]} {RNA1310_45206} {RNA815_28788} Mlig455_014448 {REF} {Length: 1455} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=63.2, Expect=6e-12]} {RNA1310_45206} {RNA815_28788} |
|
12. | MligTC455_45173 | 1421 | 29.61 | Mlig455_000256 | Neo: - Age: Up-Down-Up Region-enriched R2: 2.313/0.00035 |
3.336 | 0.793 | - | - | 0.966 | 0.719 | 0.858 | Mlig455_000256 {REF} {Length: 574} {RNA1509_48066} {RNA1310_71808.1} {RNA815_32033} | |
13. | MligTC455_45174 | 1447 | 30.15 | Mlig455_058539 | Neo: - Age: - Region-enriched R2: 2.293/0.00024 |
MLX | 3.33 | 0.796 | - | - | 0.966 | 0.713 | 0.855 | Mlig455_058539 {REF} {Length: 4178} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=41.6]} {Human: ENSG00000108788, MLX, MLX, MAX dimerization protein, [RH, Score=145, Expect=5e-42]} {Mouse: ENSMUSG00000017801, Mlx, MAX-like protein X, [RH, Score=144, Expect=8e-42]} {Dmel: FBgn0039509, bigmax, [RH, Score=130, Expect=2e-36]} {Smed: dd_Smed_v6_3140_0_1, dd_Smed_v6_3140_0_1, [RH, Score=163, Expect=3e-48]} {RNA1509_10793} {RNA1310_22883.1, RNA1509_10793} {RNA1509_10793, RNA815_10829} |
14. | MligTC455_34525 | 52 | 1.08 | Mlig455_021566 | Neo: - Age: Down-Up-Down |
GNAI1 | 3.329 | 0.982 | - | 0.705 | 0.937 | - | 0.705 | Mlig455_021566 {REF} {Length: 3532} {Pfam: G-protein alpha subunit [PF00503.22, score=404.9]; ADP-ribosylation factor family [PF00025.23, score=56.0]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=20.1]; Gtr1/RagA G protein conserved region [PF04670.14, score=19.4]} {Human: ENSG00000127955, GNAI1, G protein subunit alpha i1, [Score=486, Expect=2e-171]; ENSG00000114353, GNAI2, G protein subunit alpha i2, [Score=481, Expect=3e-169]; ENSG00000065135, GNAI3, G protein subunit alpha i3, [Score=474, Expect=1e-166]} {Mouse: ENSMUSG00000057614, Gnai1, guanine nucleotide binding protein (G protein), alpha inhibiting 1, [Score=486, Expect=2e-171]; ENSMUSG00000032562, Gnai2, guanine nucleotide binding protein (G protein), alpha inhibiting 2, [Score=475, Expect=5e-167]; ENSMUSG00000000001, Gnai3, guanine nucleotide binding protein (G protein), alpha inhibiting 3, [Score=474, Expect=1e-166]} {Dmel: FBgn0001104, Galphai, G protein alpha i subunit, [Score=468, Expect=2e-164]} {Celegans: WBGene00001648, goa-1, Guanine nucleotide-binding protein G(o) subunit alpha, [Score=446, Expect=5e-156]} {Smed: dd_Smed_v6_12112_0_1, dd_Smed_v6_12112_0_1, [RH, Score=598, Expect=0.0]} {RNA1509_45426} {RNA1310_26920, RNA1509_45426} {RNA1509_45426, RNA815_11718} |
15. | MligTC455_37200 | 32 | 0.67 | Mlig455_030215, Mlig455_030221, Mlig455_067995, Mlig455_067998 | Neo: - Age: - |
2.94 | 0.977 | - | - | 0.993 | - | 0.970 | Mlig455_030215 {REF} {Length: 1088} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=23.5]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=106, Expect=1e-25]} {RNA1310_102374} Mlig455_030221 {REF} {Length: 1980} {RNA1310_56149} {RNA815_31265} Mlig455_067995 {REF} {Length: 792} {Pfam: SAP domain [PF02037.29, score=35.7]} {RNA1509_8096} {RNA1310_1771} {RNA815_801} Mlig455_067998 {REF} {Length: 1295} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=24.0]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=105, Expect=2e-25]} {RNA1310_102374} |
|
16. | MligTC455_10299 | 72 | 1.51 | Mlig455_023028, Mlig455_023125, Mlig455_023183 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.617 Region-enriched R2: 4.572/0.04281 |
ANGPTL1 | 2.888 | 0.989 | - | - | 0.957 | - | 0.942 | Mlig455_023028 {REF} {Length: 2538} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=130.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=115, Expect=8e-29]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=112, Expect=1e-27]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=114, Expect=2e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=112, Expect=9e-28]} {Dmel: FBgn0050280, CG30280, [Score=103, Expect=9e-26]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=50.8, Expect=4e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} Mlig455_023125 {REF} {Length: 2398} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=127.5]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=112, Expect=2e-27]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=107, Expect=1e-25]} {Mouse: ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=107, Expect=7e-26]} {Dmel: FBgn0050280, CG30280, [Score=92.8, Expect=6e-22]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=51.2, Expect=3e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} Mlig455_023183 {REF} {Length: 2190} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=115, Expect=2e-28]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=110, Expect=9e-27]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=113, Expect=4e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=110, Expect=6e-27]} {Dmel: FBgn0003326, sca, scabrous, [Score=104, Expect=8e-25]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=50.4, Expect=4e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} |
17. | MligTC455_51194 | 408 | 8.5 | Mlig455_007624, Mlig455_007645 | Neo: - Age: - Region-specific R2: 3.993 Region-enriched R2: 3.717/0.00015 |
CDK5R1 | 2.818 | 0.976 | - | - | 0.978 | - | 0.864 | Mlig455_007624 {REF} {Length: 1990} {Pfam: Cyclin-dependent kinase 5 activator protein [PF03261.17, score=249.2]} {Human: ENSG00000176749, CDK5R1, cyclin dependent kinase 5 regulatory subunit 1, [RH, Score=191, Expect=7e-57]} {Mouse: ENSMUSG00000048895, Cdk5r1, cyclin-dependent kinase 5, regulatory subunit 1 (p35), [RH, Score=191, Expect=6e-57]} {Dmel: FBgn0027491, Cdk5alpha, Cdk5 activator-like protein, [RH, Score=199, Expect=2e-58]} {Celegans: WBGene00011955, cdka-1, Cyclin-dependent kinase 5 activator 1, [RH, Score=176, Expect=6e-51]} {Smed: dd_Smed_v6_13788_0_1, dd_Smed_v6_13788_0_1, [RH, Score=215, Expect=1e-66]} {RNA1509_28436} {RNA1310_14097} {RNA815_13436} Mlig455_007645 {REF} {Length: 1937} {Pfam: Cyclin-dependent kinase 5 activator protein [PF03261.17, score=249.3]} {Human: ENSG00000176749, CDK5R1, cyclin dependent kinase 5 regulatory subunit 1, [RH, Score=191, Expect=8e-57]} {Mouse: ENSMUSG00000048895, Cdk5r1, cyclin-dependent kinase 5, regulatory subunit 1 (p35), [RH, Score=191, Expect=5e-57]} {Dmel: FBgn0027491, Cdk5alpha, Cdk5 activator-like protein, [RH, Score=199, Expect=3e-58]} {Celegans: WBGene00011955, cdka-1, Cyclin-dependent kinase 5 activator 1, [RH, Score=177, Expect=2e-51]} {Smed: dd_Smed_v6_13788_0_1, dd_Smed_v6_13788_0_1, [RH, Score=216, Expect=1e-66]} {RNA1509_28436} {RNA1310_14097} {RNA815_13436} |
18. | MligTC455_09472 | 23 | 0.47 | Mlig455_059329 | Neo: - Age: - |
NGB | 2.791 | 0.977 | - | - | 0.942 | 0.872 | - | Mlig455_059329 {REF} {Length: 2110} {Pfam: Globin [PF00042.24, score=52.9]} {Human: ENSG00000165553, NGB, neuroglobin, [RH, Score=48.5, Expect=8e-07]} {Mouse: ENSMUSG00000021032, Ngb, neuroglobin, [RH, Score=50.4, Expect=1e-07]} {RNA1310_93460} {RNA815_18392} |
19. | MligTC455_51557 | 57 | 1.19 | Mlig455_038195 | Neo: - Age: Down-Up-Up |
ISL1 | 2.765 | 0.966 | - | 0.827 | 0.972 | - | - | Mlig455_038195 {REF} {Length: 2149} {Pfam: LIM domain [PF00412.24, score=91.4]; Homeodomain [PF00046.31, score=55.3]; Homeobox KN domain [PF05920.13, score=23.4]} {Human: ENSG00000016082, ISL1, ISL LIM homeobox 1, [Score=180, Expect=9e-52]; ENSG00000159556, ISL2, ISL LIM homeobox 2, [Score=173, Expect=3e-49]} {Mouse: ENSMUSG00000042258, Isl1, ISL1 transcription factor, LIM/homeodomain, [Score=180, Expect=6e-52]; ENSMUSG00000032318, Isl2, insulin related protein 2 (islet 2), [Score=175, Expect=4e-50]} {Dmel: FBgn0003896, tup, tailup, [Score=151, Expect=3e-40]} {Celegans: WBGene00002989, lim-7, CeLIM-7; LIM domain family, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8820_0_1, dd_Smed_v6_8820_0_1, [Score=303, Expect=1e-97]} {RNA1310_54855} {RNA815_46288} |
20. | MligTC455_12574 | 95 | 1.98 | Mlig455_010864, Mlig455_010895 | Neo: - Age: - |
2.733 | 0.971 | - | 0.767 | 0.995 | - | - | Mlig455_010864 {REF} {Length: 886} {RNA1310_70414} {RNA815_36183} Mlig455_010895 {REF} {Length: 627} {RNA1310_70414} {RNA815_36183} |
|
21. | MligTC455_24568 | 25 | 0.51 | Mlig455_038127 | Neo: - Age: Down-Up-Down |
CACNA2D2 | 2.706 | 0.968 | - | - | 0.945 | 0.793 | - | Mlig455_038127 {REF} {Length: 4202} {Pfam: von Willebrand factor type A domain [PF13519.8, score=41.5]; von Willebrand factor type A domain [PF00092.30, score=36.2]; von Willebrand factor type A domain [PF13768.8, score=30.8]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [Score=82.8, Expect=2e-16]; ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=79.3, Expect=3e-15]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=79.0, Expect=4e-15]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [Score=82.4, Expect=2e-16]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [Score=79.3, Expect=3e-15]} {Celegans: WBGene00007041, tag-180, [Score=62.0, Expect=4e-10]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=430, Expect=2e-140]} {RNA1509_28096} {RNA1310_2030} {RNA815_1872} |
22. | MligTC455_29914 | 44 | 0.91 | Mlig455_027923 | Neo: - Age: Down-Up-Down Region-enriched R2: 8.096/0.00455 |
ANGPTL3 | 2.705 | 0.976 | - | - | 0.898 | 0.831 | - | Mlig455_027923 {REF} {Length: 1663} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=70.5]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=60.5, Expect=9e-10]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=59.3, Expect=2e-09]; ENSG00000120332, TNN, tenascin N, [Score=58.9, Expect=3e-09]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=62.4, Expect=2e-10]} {Dmel: FBgn0031804, CG9500, [Score=76.3, Expect=6e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=51.2, Expect=3e-07]} {RNA1509_53291} {RNA1310_58974} {RNA815_43288.3} |
23. | MligTC455_49334 | 86 | 1.78 | Mlig455_037751 | Neo: - Age: - |
2.704 | 0.992 | - | - | 0.995 | - | 0.717 | Mlig455_037751 {REF} {Length: 708} {RNA1509_25826} {RNA1310_47741} {RNA815_23874} | |
24. | MligTC455_52656 | 121 | 2.51 | Mlig455_062381, Mlig455_062408 | Neo: - Age: Down-Up-Down |
2.702 | 0.985 | - | - | 0.975 | 0.742 | - | Mlig455_062381 {REF} {Length: 2245} {RNA1310_26272} {RNA815_22826} Mlig455_062408 {REF} {Length: 2277} {RNA1310_26272} {RNA815_37592} |
|
25. | MligTC455_13421 | 86 | 1.79 | Mlig455_036504, Mlig455_069144 | Neo: - Age: - |
SYT17 | 2.696 | 0.969 | - | 0.809 | 0.918 | - | - | Mlig455_036504 {REF} {Length: 2390} {Pfam: C2 domain [PF00168.32, score=84.3]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=137, Expect=5e-35]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=137, Expect=6e-35]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=101, Expect=1e-22]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=105, Expect=2e-24]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [RH, Score=124, Expect=2e-30]} {RNA1310_17303} {RNA815_33031} Mlig455_069144 {REF} {Length: 1355} {Pfam: C2 domain [PF00168.32, score=84.3]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=137, Expect=5e-35]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=137, Expect=6e-35]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=101, Expect=1e-22]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=105, Expect=2e-24]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [RH, Score=124, Expect=2e-30]} {RNA1310_17303} {RNA815_33031} |
26. | MligTC455_13935 | 206 | 4.3 | Mlig455_019165 | Neo: - Age: Up-Up-Down Region-enriched R2: 3.248/0.00981 |
2.696 | 0.870 | - | 0.868 | 0.958 | - | - | Mlig455_019165 {REF} {Length: 3759} {Pfam: Major Facilitator Superfamily [PF07690.18, score=92.7]; MFS/sugar transport protein [PF13347.8, score=41.5]; MFS_1 like family [PF12832.9, score=37.3]; PUCC protein [PF03209.17, score=28.6]} {Smed: dd_Smed_v6_8550_0_1, dd_Smed_v6_8550_0_1, [RH, Score=441, Expect=4e-150]} {RNA1509_28461, RNA1509_55131} {RNA1310_7716, RNA1509_28461, RNA1509_55131} {RNA1509_28461, RNA1509_55131, RNA815_2811.1} | |
27. | MligTC455_24407 | 222 | 4.63 | Mlig455_044026 | Neo: - Age: Down-Up-Up Region-specific R2: 3.725 Region-enriched R2: 3.414/0.00001 |
2.695 | 0.942 | - | 0.767 | 0.986 | - | - | Mlig455_044026 {REF} {Length: 503} {RNA1509_54091} {RNA1310_68348.1} {RNA815_33570.1} | |
28. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
2.691 | 0.977 | - | - | 0.994 | - | 0.720 | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
29. | MligTC455_38949 | 105 | 2.19 | Mlig455_065209 | Neo: - Age: - Region-specific R2: 7.633 Region-enriched R2: 10.088/0.00000 |
2.691 | 0.982 | - | - | 0.991 | - | 0.718 | Mlig455_065209 {REF} {Length: 591} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=23.2]} {RNA1509_44618} {RNA1310_63839, RNA1509_44618} {RNA1509_44618, RNA815_35329} | |
30. | MligTC455_44966 | 574 | 11.95 | Mlig455_036578, Mlig455_057773 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.756 Region-specific R2: 7.016 Region-enriched R2: 7.690/0.00000 |
2.689 | 0.980 | - | - | 0.995 | - | 0.714 | Mlig455_036578 {REF} {Length: 1101} {RNA1509_34765} {RNA1310_57079} {RNA815_29388} Mlig455_057773 {REF} {Length: 629} {RNA1509_34765} {RNA1310_57079, RNA1509_34765} {RNA1509_34765, RNA815_29388} |
|
31. | MligTC455_34524 | 155 | 3.22 | Mlig455_021291 | Neo: - Age: Down-Up-Down Region-specific R2: 4.905 Region-enriched R2: 4.200/0.01842 |
2.688 | 0.989 | - | - | 0.997 | 0.702 | - | Mlig455_021291 {REF} {Length: 1478} {NoTransDecoderORF} {RNA1509_56543} {RNA1310_26920, RNA1509_56543} {RNA1509_56543, RNA815_11718} | |
32. | MligTC455_45943 | 66 | 1.38 | Mlig455_012164 | Neo: - Age: Up-Up-Down |
NPR2 | 2.688 | 0.952 | - | - | 0.984 | 0.752 | - | Mlig455_012164 {REF} {Length: 4580} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=225.3]; Receptor family ligand binding region [PF01094.30, score=169.5]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=126.7]; Protein kinase domain [PF00069.27, score=114.0]; Heme NO binding associated [PF07701.16, score=19.2]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [RH, Score=791, Expect=0.0]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [RH, Score=629, Expect=0.0]} {Dmel: FBgn0051183, CG31183, [RH, Score=826, Expect=0.0]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [RH, Score=600, Expect=0.0]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [RH, Score=955, Expect=0.0]} {RNA1509_42903} {RNA1310_5627} {RNA815_1811} |
33. | MligTC455_41396 | 187 | 3.9 | Mlig455_012937, Mlig455_031470 | Neo: - Age: - Region-enriched R2: 4.167/0.01146 |
2.686 | 0.948 | - | - | 0.963 | 0.775 | - | Mlig455_012937 {REF} {Length: 1911} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [Score=46.6, Expect=1e-06]} {RNA1509_16138} {RNA1310_24329} {RNA815_11818} Mlig455_031470 {REF} {Length: 1745} {Dmel: FBgn0083971, CG34135, [RH, Score=60.1, Expect=1e-10]} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [RH, Score=96.3, Expect=3e-23]} {RNA1509_16138} {RNA1310_24329} {RNA815_11818} |
|
34. | MligTC455_50253 | 44 | 0.92 | Mlig455_031495 | Neo: - Age: - |
GABRB2 | 2.686 | 0.983 | - | - | 0.992 | - | 0.711 | Mlig455_031495 {REF} {Length: 2129} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=58.3]} {Human: ENSG00000145864, GABRB2, gamma-aminobutyric acid type A receptor beta2 subunit, [Score=71.2, Expect=6e-14]} {Mouse: ENSMUSG00000007653, Gabrb2, gamma-aminobutyric acid (GABA) A receptor, subunit beta 2, [Score=67.8, Expect=1e-12]; ENSMUSG00000029212, Gabrb1, gamma-aminobutyric acid (GABA) A receptor, subunit beta 1, [Score=67.4, Expect=1e-12]} {Dmel: FBgn0024963, GluClalpha, [Score=54.3, Expect=3e-08]} {Celegans: WBGene00001594, glc-4, Glutamate-gated ChLoride channel, [Score=66.6, Expect=2e-12]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=70.1, Expect=9e-14]} {RNA1310_46931} {RNA815_25428} |
35. | MligTC455_17051 | 22 | 0.46 | Mlig455_042552 | Neo: - Age: - |
GRIA4 | 2.685 | 0.988 | - | - | 0.977 | - | 0.720 | Mlig455_042552 {REF} {Length: 3307} {Pfam: Ligand-gated ion channel [PF00060.28, score=83.3]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=45.2]; Receptor family ligand binding region [PF01094.30, score=25.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=19.8]} {Human: ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=139, Expect=2e-33]} {Mouse: ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=139, Expect=3e-33]} {Dmel: FBgn0038837, CG3822, [Score=142, Expect=2e-34]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=109, Expect=2e-24]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=246, Expect=7e-74]} {RNA1310_33224} {RNA815_17044} |
36. | MligTC455_14483 | 140 | 2.92 | Mlig455_028240 | Neo: - Age: - Region-enriched R2: 6.203/0.04837 |
2.684 | 0.977 | - | - | 0.990 | - | 0.717 | Mlig455_028240 {REF} {Length: 728} {RNA1310_111517} {RNA815_9716} | |
37. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 2.684 | 0.980 | - | - | 0.995 | - | 0.709 | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |
38. | MligTC455_50355 | 38 | 0.79 | Mlig455_057631 | Neo: - Age: - Region-enriched R2: 7.639/0.01837 |
2.679 | 0.975 | - | - | 0.986 | - | 0.718 | Mlig455_057631 {REF} {Length: 1003} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=47.4, Expect=6e-06]} {RNA1310_44307} {RNA815_33128} | |
39. | MligTC455_17177 | 103 | 2.15 | Mlig455_048992, Mlig455_049009 | Neo: - Age: Down-Down-Up |
2.678 | 0.977 | - | - | 0.981 | - | 0.720 | Mlig455_048992 {REF} {Length: 1836} {RNA1509_44702} {RNA1310_14743, RNA1509_44702} {RNA1509_44702, RNA815_20669.1} Mlig455_049009 {REF} {Length: 1823} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} |
|
40. | MligTC455_19709 | 221 | 4.6 | Mlig455_010385 | Neo: - Age: - Region-enriched R2: 4.689/0.03280 |
2.676 | 0.977 | - | - | 0.998 | 0.701 | - | Mlig455_010385 {REF} {Length: 903} {Pfam: Pancreatic hormone peptide [PF00159.20, score=43.2]} {RNA1509_54211} {RNA1310_54505.2} {RNA815_29389} | |
41. | MligTC455_15859 | 120 | 2.49 | Mlig455_007414, Mlig455_067681 | Neo: - Age: - |
2.673 | 0.977 | - | - | 0.977 | - | 0.719 | Mlig455_007414 {REF} {Length: 914} {RNA1310_61579} {RNA815_24378} Mlig455_067681 {REF} {Length: 917} {RNA1310_61579} {RNA815_24378} |
|
42. | MligTC455_46543 | 178 | 3.7 | Mlig455_000344, Mlig455_067946 | Neo: - Age: - Region-specific R2: 6.098 Region-enriched R2: 6.851/0.00000 |
2.672 | 0.804 | - | - | 0.913 | - | 0.955 | Mlig455_000344 {REF} {Length: 1920} {RNA1310_82457} {RNA815_33120} Mlig455_067946 {REF} {Length: 1217} {RNA1310_99435} |
|
43. | MligTC455_20390 | 87 | 1.82 | Mlig455_051716 | Neo: - Age: - |
SLC1A2 | 2.671 | 0.848 | - | - | 0.964 | 0.859 | - | Mlig455_051716 {REF} {Length: 4683} {Pfam: Sodium:dicarboxylate symporter family [PF00375.20, score=432.6]} {Human: ENSG00000110436, SLC1A2, solute carrier family 1 member 2, [RH, Score=530, Expect=0.0]} {Mouse: ENSMUSG00000005089, Slc1a2, solute carrier family 1 (glial high affinity glutamate transporter), member 2, [RH, Score=545, Expect=0.0]} {Dmel: FBgn0026439, Eaat1, Excitatory amino acid transporter 1, [RH, Score=375, Expect=4e-124]} {Celegans: WBGene00001620, glt-1, Excitatory amino acid transporter, [RH, Score=517, Expect=1e-179]} {Smed: dd_Smed_v6_7570_0_1, dd_Smed_v6_7570_0_1, [RH, Score=611, Expect=0.0]} {RNA1509_31315} {RNA1310_5180} {RNA815_8754} |
44. | MligTC455_33854 | 41 | 0.85 | Mlig455_031601 | Neo: - Age: - Region-enriched R2: 5.730/0.00808 |
2.671 | 0.972 | - | - | 0.958 | 0.741 | - | Mlig455_031601 {REF} {Length: 1072} {RNA1310_42312} {RNA815_56269} | |
45. | MligTC455_42520 | 221 | 4.6 | Mlig455_051277 | Neo: - Age: Down-Up-Up Region-specific R2: 7.331 Region-enriched R2: 7.171/0.00000 Regeneration-downregulated R2: -3.384 Regeneration-depleted R2: -3.384 |
2.671 | 0.977 | - | - | 0.987 | - | 0.707 | Mlig455_051277 {REF} {Length: 969} {RNA1310_42329} {RNA815_20649} | |
46. | MligTC455_41382 | 65 | 1.35 | Mlig455_022554 | Neo: - Age: - Region-enriched R2: 5.596/0.01432 |
2.667 | 0.977 | - | - | 0.970 | - | 0.720 | Mlig455_022554 {REF} {Length: 503} {Pfam: Pancreatic hormone peptide [PF00159.20, score=18.9]} {RNA1310_81495} {RNA815_42745} | |
47. | MligTC455_21502 | 36 | 0.75 | Mlig455_018529 | Neo: - Age: - Region-enriched R2: 5.380/0.01311 |
2.666 | 0.970 | - | - | 0.926 | 0.770 | - | Mlig455_018529 {REF} {Length: 1004} {Pfam: Fas apoptotic inhibitory molecule (FAIM1) [PF06905.15, score=43.7]} {Mouse: ENSMUSG00000032463, Faim, Fas apoptotic inhibitory molecule, [Score=54.7, Expect=2e-09]} {Smed: dd_Smed_v6_4798_0_1, dd_Smed_v6_4798_0_1, [RH, Score=75.1, Expect=7e-18]} {RNA1310_42034} {RNA815_19884} | |
48. | MligTC455_36944 | 22 | 0.45 | Mlig455_065298, Mlig455_065320 | Neo: - Age: Up-Down-Up |
NR2F1 | 2.662 | 0.967 | - | - | 0.903 | 0.792 | - | Mlig455_065298 {REF} {Length: 2485} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=100.7]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=95.1]} {Human: ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [RH, Score=241, Expect=4e-73]; ENSG00000185551, NR2F2, nuclear receptor subfamily 2 group F member 2, [RH, Score=240, Expect=2e-72]} {Mouse: ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [RH, Score=240, Expect=2e-72]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [RH, Score=240, Expect=1e-72]} {Dmel: FBgn0003651, svp, seven up, [RH, Score=240, Expect=3e-71]} {Celegans: WBGene00006790, unc-55, UNC-55b isoform, [RH, Score=150, Expect=4e-40]} {Smed: dd_Smed_v6_33286_0_1, dd_Smed_v6_33286_0_1, [RH, Score=211, Expect=4e-61]} Mlig455_065320 {REF} {Length: 3080} {Pfam: Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=76.1]} {Human: ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [Score=215, Expect=6e-67]; ENSG00000185551, NR2F2, nuclear receptor subfamily 2 group F member 2, [Score=214, Expect=5e-66]} {Mouse: ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [Score=215, Expect=2e-68]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [Score=214, Expect=4e-66]} {Dmel: FBgn0003651, svp, seven up, [Score=211, Expect=2e-66]} {Celegans: WBGene00006790, unc-55, UNC-55b isoform, [Score=69.3, Expect=4e-13]} {Smed: dd_Smed_v6_33286_0_1, dd_Smed_v6_33286_0_1, [Score=183, Expect=9e-54]} |
49. | MligTC455_34369 | 112 | 2.34 | Mlig455_015308, Mlig455_015354, Mlig455_036248, Mlig455_068737, Mlig455_070110 | Neo: - Age: Up-Down-Up Region-enriched R2: 5.462/0.00546 |
2.658 | 0.975 | - | - | 0.930 | 0.753 | - | Mlig455_015308 {REF} {Length: 1459} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.9]} {RNA1310_34740} {RNA815_15663} Mlig455_015354 {REF} {Length: 1446} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=66.3]; Sialidase, N-terminal domain [PF02973.18, score=18.5]} {RNA1310_34740} {RNA815_15663} Mlig455_036248 {REF} {Length: 2111} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=120.9]; Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=28.5]; PAN domain [PF00024.28, score=19.9]} {RNA1509_45496} {RNA1310_2539.1} {RNA815_252.1} Mlig455_068737 {REF} {Length: 1096} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=68.3]; Sialidase, N-terminal domain [PF02973.18, score=19.9]} {RNA1310_34740} {RNA815_37905} Mlig455_070110 {REF} {Length: 1340} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=109.6]} {RNA1509_32599} {RNA1310_1659} {RNA815_252.1} |
|
50. | MligTC455_26356 | 62 | 1.3 | Mlig455_042551 | Neo: - |
GRIK2 | 2.652 | 0.976 | - | - | 0.956 | - | 0.720 | Mlig455_042551 {REF} {Length: 2917} {Pfam: Ligand-gated ion channel [PF00060.28, score=82.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=60.7]; Receptor family ligand binding region [PF01094.30, score=32.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=27.3]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=144, Expect=9e-35]; ENSG00000152208, GRID2, glutamate ionotropic receptor delta type subunit 2, [Score=141, Expect=7e-34]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=143, Expect=1e-34]; ENSMUSG00000071424, Grid2, glutamate receptor, ionotropic, delta 2, [Score=142, Expect=2e-34]} {Dmel: FBgn0051201, GluRIIE, Glutamate receptor IIE, [Score=119, Expect=3e-27]} {Celegans: WBGene00001616, glr-5, GLutamate Receptor family (AMPA), [Score=123, Expect=2e-28]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=247, Expect=4e-74]} {RNA1310_21865} {RNA815_26044} |
51. | MligTC455_44956 | 144 | 2.99 | Mlig455_061510 | Neo: - Age: - |
2.648 | 0.908 | - | 0.750 | 0.990 | - | - | Mlig455_061510 {REF} {Length: 493} {Pfam: Pancreatic hormone peptide [PF00159.20, score=31.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.8, Expect=9e-09]} {RNA1509_17163} {RNA1310_66833.1} {RNA815_41767} | |
52. | MligTC455_18099 | 24 | 0.51 | Mlig455_036525 | Neo: - Age: - |
PPA1 | 2.643 | 0.977 | - | - | 0.952 | - | 0.714 | Mlig455_036525 {REF} {Length: 1911} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1310_57333.1} {RNA815_22340} |
53. | MligTC455_18748 | 104 | 2.17 | Mlig455_024985, Mlig455_024999 | Neo: - Age: - Region-enriched R2: 6.002/0.00016 |
GRIK4 | 2.643 | 0.944 | - | - | 0.990 | - | 0.709 | Mlig455_024985 {REF} {Length: 1514} {Pfam: Ligand-gated ion channel [PF00060.28, score=76.7]; Receptor family ligand binding region [PF01094.30, score=31.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.6]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=122, Expect=1e-27]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=124, Expect=1e-28]} {Dmel: FBgn0038837, CG3822, [Score=120, Expect=1e-27]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=99.0, Expect=5e-21]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=196, Expect=2e-55]} {RNA1509_35538} {RNA1310_47299} {RNA815_38321} Mlig455_024999 {REF} {Length: 3567} {Pfam: Ligand-gated ion channel [PF00060.28, score=76.7]; Receptor family ligand binding region [PF01094.30, score=31.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.6]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=122, Expect=1e-27]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=124, Expect=1e-28]} {Dmel: FBgn0038837, CG3822, [Score=120, Expect=1e-27]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=99.0, Expect=5e-21]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=196, Expect=2e-55]} {RNA1509_35538} {RNA1310_7578, RNA1509_35538} {RNA1509_35538, RNA815_4987} |
54. | MligTC455_19716 | 35 | 0.73 | Mlig455_008148 | Neo: - Age: - |
NPY1R | 2.642 | 0.931 | - | - | 0.967 | 0.744 | - | Mlig455_008148 {REF} {Length: 3212} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=183.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=36.4]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [RH, Score=167, Expect=8e-47]} {Mouse: ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=170, Expect=8e-48]; ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [RH, Score=167, Expect=7e-47]} {Dmel: FBgn0036934, sNPF-R, short neuropeptide F receptor, [RH, Score=256, Expect=1e-78]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [RH, Score=220, Expect=3e-67]} {Smed: dd_Smed_v6_10020_0_1, dd_Smed_v6_10020_0_1, [RH, Score=336, Expect=1e-112]} {RNA1310_21371} {RNA815_7986} |
55. | MligTC455_35019 | 168 | 3.49 | Mlig455_046994 | Neo: - Age: - |
ASIC4 | 2.641 | 0.964 | - | - | 0.801 | 0.876 | - | Mlig455_046994 {REF} {Length: 4001} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=101.4]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=76.3, Expect=1e-13]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=76.3, Expect=8e-14]; ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=72.8, Expect=8e-13]} {Smed: dd_Smed_v6_15233_0_1, dd_Smed_v6_15233_0_1, [RH, Score=103, Expect=1e-22]} {RNA1509_33816} {RNA1310_3176, RNA1509_33816} {RNA1509_33816, RNA815_12439} |
56. | MligTC455_51334 | 326 | 6.78 | Mlig455_011442, Mlig455_061180 | Neo: - |
2.641 | 0.925 | - | - | 0.998 | - | 0.718 | Mlig455_011442 {REF} {Length: 742} {RNA1310_57576.1} {RNA815_29867} Mlig455_061180 {REF} {Length: 769} {RNA1310_57576.1} {RNA815_29867} |
|
57. | MligTC455_24064 | 359 | 7.48 | Mlig455_048183 | Neo: - Age: - |
SNAP25 | 2.638 | 0.965 | - | - | 0.898 | 0.775 | - | Mlig455_048183 {REF} {Length: 1315} {Pfam: SNAP-25 family [PF00835.21, score=41.5]} {Human: ENSG00000132639, SNAP25, synaptosome associated protein 25, [Score=219, Expect=7e-72]} {Mouse: ENSMUSG00000027273, Snap25, synaptosomal-associated protein 25, [Score=219, Expect=5e-72]} {Dmel: FBgn0266720, Snap24, Synaptosomal-associated protein 24kDa, [RH, Score=228, Expect=1e-75]} {Celegans: WBGene00004364, ric-4, Synaptosomal-associated protein, [RH, Score=257, Expect=2e-87]} {Smed: dd_Smed_v6_3977_0_1, dd_Smed_v6_3977_0_1, [RH, Score=282, Expect=2e-97]} {RNA1509_8624} {RNA1310_24253} {RNA815_10439} |
58. | MligTC455_33280 | 127 | 2.64 | Mlig455_010523 | Neo: - Age: Down-Up-Up |
2.631 | 0.971 | - | 0.762 | 0.898 | - | - | Mlig455_010523 {REF} {Length: 587} {RNA1509_48963} {RNA1310_65789} {RNA815_23468} | |
59. | MligTC455_50694 | 602 | 12.54 | Mlig455_058794, Mlig455_070066 | Neo: - Age: Down-Down-Up Region-specific R2: 5.478 Region-enriched R2: 3.805/0.01454 |
2.631 | 0.930 | - | - | 0.998 | - | 0.703 | Mlig455_058794 {REF} {Length: 776} {RNA1310_76208} {RNA815_49041} Mlig455_070066 {REF} {Length: 781} {RNA1310_76208} {RNA815_49041} |
|
60. | MligTC455_12512 | 80 | 1.68 | Mlig455_017689 | Neo: - Age: - |
2.622 | 0.977 | - | - | 0.928 | - | 0.717 | Mlig455_017689 {REF} {Length: 934} {RNA1310_37507} {RNA815_32171} | |
61. | MligTC455_19041 | 54 | 1.12 | Mlig455_030662 | Neo: - Age: - Region-enriched R2: 9.337/0.00002 |
CAV1 | 2.619 | 0.976 | - | - | 0.912 | 0.731 | - | Mlig455_030662 {REF} {Length: 940} {Pfam: Caveolin [PF01146.19, score=117.8]} {Human: ENSG00000105974, CAV1, caveolin 1, [Score=98.2, Expect=1e-26]} {Mouse: ENSMUSG00000007655, Cav1, caveolin 1, caveolae protein, [Score=99.4, Expect=3e-27]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=73.9, Expect=6e-17]} {Smed: dd_Smed_v6_6535_0_1, dd_Smed_v6_6535_0_1, [RH, Score=133, Expect=6e-41]} {RNA1509_53325} {RNA1310_97043} {RNA815_32565} |
62. | MligTC455_12269 | 42 | 0.88 | Mlig455_062448 | Neo: - Age: - Region-enriched R2: 6.351/0.02912 |
2.616 | 0.911 | - | - | 0.986 | - | 0.719 | Mlig455_062448 {REF} {Length: 941} {RNA1310_43338} {RNA815_24238} | |
63. | MligTC455_33831 | 198 | 4.13 | Mlig455_029369 | Neo: - Age: - Region-enriched R2: 3.223/0.02852 Regeneration-downregulated TP: -7.340 Regeneration-depleted TP: -7.340 |
GLRA3 | 2.612 | 0.841 | - | - | 0.964 | 0.807 | - | Mlig455_029369 {REF} {Length: 3665} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.5]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=257, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=253, Expect=2e-78]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=250, Expect=4e-77]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=251, Expect=2e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=3e-77]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=1e-76]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=243, Expect=1e-74]} {Dmel: FBgn0024963, GluClalpha, [Score=253, Expect=2e-78]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=259, Expect=5e-81]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=480, Expect=2e-167]} {RNA1509_35986} {RNA1310_35528} {RNA815_11925.1} |
64. | MligTC455_23544 | 169 | 3.53 | Mlig455_021925 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.394/0.00033 |
DDR2 | 2.611 | 0.958 | - | - | 0.878 | 0.775 | - | Mlig455_021925 {REF} {Length: 4813} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=205.5]; Protein kinase domain [PF00069.27, score=103.7]; F5/8 type C domain [PF00754.27, score=57.5]} {Human: ENSG00000162733, DDR2, discoidin domain receptor tyrosine kinase 2, [Score=249, Expect=1e-68]} {Mouse: ENSMUSG00000026674, Ddr2, discoidin domain receptor family, member 2, [Score=251, Expect=1e-69]} {Dmel: FBgn0053531, Ddr, Discoidin domain receptor, [Score=238, Expect=3e-64]} {Celegans: WBGene00017381, svh-4, Discoidin domain-containing receptor tyrosine kinase B, [Score=176, Expect=3e-45]} {Smed: dd_Smed_v6_22332_0_1, dd_Smed_v6_22332_0_1, [Score=187, Expect=2e-48]} {RNA1509_46581} {RNA1310_21361} {RNA815_21661} |
65. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
2.611 | 0.895 | - | - | 0.998 | - | 0.718 | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
66. | MligTC455_12102 | 59 | 1.23 | Mlig455_041538, Mlig455_053099 | Neo: - Age: - Region-enriched R2: 6.626/0.00371 |
DEGS2 | 2.608 | 0.990 | - | 0.746 | 0.872 | - | - | Mlig455_041538 {REF} {Length: 1966} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.6]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=5e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=308, Expect=2e-103]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=6e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=5e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=4e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=7e-143]} {RNA1310_20672.2} {RNA815_19986} Mlig455_053099 {REF} {Length: 2009} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.5]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=4e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=309, Expect=7e-104]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=5e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=4e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=3e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=4e-143]} {RNA1310_20672.1} {RNA815_19986} |
67. | MligTC455_38162 | 710 | 14.8 | Mlig455_045004 | Neo: - Age: Down-Up-Up Region-specific R2: 5.269 Region-enriched R2: 5.838/0.00000 Regeneration-downregulated R2: -4.412 Regeneration-depleted R2: -4.412 |
2.607 | 0.932 | - | - | 0.962 | - | 0.713 | Mlig455_045004 {REF} {Length: 659} {Smed: dd_Smed_v6_4046_0_1, dd_Smed_v6_4046_0_1, [Score=57.8, Expect=2e-12]} {RNA1509_50998, RNA1509_57106} {RNA1310_56015, RNA1509_50998, RNA1509_57106} {RNA1509_50998, RNA1509_57106, RNA815_29915} | |
68. | MligTC455_51228 | 99 | 2.07 | Mlig455_021448 | Neo: - Age: - |
ANK2 | 2.596 | 0.806 | - | - | 0.812 | - | 0.978 | Mlig455_021448 {REF} {Length: 6454} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=535.9]; Ankyrin repeat [PF00023.32, score=442.4]; Ankyrin repeats (many copies) [PF13637.8, score=435.7]; Ankyrin repeat [PF13606.8, score=370.1]; Ankyrin repeats (many copies) [PF13857.8, score=364.9]; Ion transport protein [PF00520.33, score=37.4]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=325, Expect=3e-89]; ENSG00000151150, ANK3, ankyrin 3, [Score=323, Expect=2e-88]; ENSG00000029534, ANK1, ankyrin 1, [Score=312, Expect=3e-85]} {Mouse: ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=352, Expect=2e-97]} {Dmel: FBgn0016920, nompC, no mechanoreceptor potential C, [RH, Score=1339, Expect=0.0]} {Celegans: WBGene00006616, trp-4, TRP (Transient receptor potential) channel family, [RH, Score=1296, Expect=0.0]} {Smed: dd_Smed_v6_21003_0_1, dd_Smed_v6_21003_0_1, [RH, Score=1614, Expect=0.0]} {RNA1509_34114} {RNA1310_1922} {RNA815_29851} |
69. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 2.592 | 0.908 | - | - | 0.982 | - | 0.702 | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
70. | MligTC455_26563 | 73 | 1.53 | Mlig455_011118 | Neo: - Age: Up-Down-Down |
2.585 | - | - | 0.951 | 0.775 | - | 0.859 | Mlig455_011118 {REF} {Length: 4946} {RNA1509_31714} {RNA1310_17466.1} {RNA815_19630.1} | |
71. | MligTC455_38178 | 19 | 0.39 | Mlig455_025460 | Neo: - Age: - |
SIX4 | 2.583 | 0.987 | - | 0.777 | - | 0.819 | - | Mlig455_025460 {REF} {Length: 2329} {Pfam: Transcriptional regulator, SIX1, N-terminal SD domain [PF16878.7, score=141.7]; Homeodomain [PF00046.31, score=57.9]; Homeobox KN domain [PF05920.13, score=40.9]} {Human: ENSG00000100625, SIX4, SIX homeobox 4, [RH, Score=271, Expect=6e-84]} {Mouse: ENSMUSG00000034460, Six4, sine oculis-related homeobox 4, [RH, Score=270, Expect=1e-83]} {Dmel: FBgn0027364, Six4, [RH, Score=254, Expect=2e-81]} {Celegans: WBGene00000454, ceh-33, Homeobox protein ceh-33, [Score=202, Expect=3e-63]} {Smed: dd_Smed_v6_37930_0_1, dd_Smed_v6_37930_0_1, [RH, Score=244, Expect=7e-79]} |
72. | MligTC455_30160 | 55 | 1.15 | Mlig455_035128 | Neo: - Age: - Region-enriched R2: 5.270/0.01686 |
TCF7L1 | 2.578 | 0.897 | - | - | 0.967 | 0.714 | - | Mlig455_035128 {REF} {Length: 2946} {Pfam: HMG (high mobility group) box [PF00505.21, score=79.2]; HMG-box domain [PF09011.12, score=34.5]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=1e-42]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=158, Expect=7e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=156, Expect=2e-41]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=161, Expect=8e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=158, Expect=9e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=1e-42]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=156, Expect=1e-40]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=6e-48]} {RNA1509_46571} {RNA1310_11181} {RNA815_36690} |
73. | MligTC455_45898 | 87 | 1.82 | Mlig455_058293 | Neo: - Age: - |
CUX2 | 2.568 | 0.970 | - | 0.776 | - | - | 0.822 | Mlig455_058293 {REF} {Length: 4328} {Pfam: CUT domain [PF02376.17, score=197.2]; Homeodomain [PF00046.31, score=53.8]; Homeobox KN domain [PF05920.13, score=29.1]} {Human: ENSG00000111249, CUX2, cut like homeobox 2, [Score=144, Expect=3e-34]} {Mouse: ENSMUSG00000042589, Cux2, cut-like homeobox 2, [Score=148, Expect=1e-35]} {Dmel: FBgn0004198, ct, cut, [Score=123, Expect=4e-28]} {Celegans: WBGene00000464, ceh-44, Homeobox protein cut-like ceh-44, [RH, Score=142, Expect=4e-34]} {Smed: dd_Smed_v6_13843_0_1, dd_Smed_v6_13843_0_1, [Score=125, Expect=6e-29]} {RNA1310_11859} {RNA815_40841} |
74. | MligTC455_49929 | 76 | 1.59 | Mlig455_001249, Mlig455_001253 | Neo: - Age: Down-Up-Up |
2.561 | 0.961 | - | 0.753 | 0.847 | - | - | Mlig455_001249 {REF} {Length: 984} {RNA1310_33799.1} {RNA815_47109} Mlig455_001253 {REF} {Length: 1260} {RNA1310_33799.1} {RNA815_45980} |
|
75. | MligTC455_46649 | 100 | 2.09 | Mlig455_023901 | Neo: - Age: Up-Down-Up Region-enriched R2: 5.216/0.00086 |
SLC46A2 | 2.56 | 0.780 | - | - | 0.979 | 0.801 | - | Mlig455_023901 {REF} {Length: 2695} {Pfam: Major Facilitator Superfamily [PF07690.18, score=79.0]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=71.6, Expect=1e-12]} {Mouse: ENSMUSG00000029650, Slc46a3, solute carrier family 46, member 3, [Score=77.4, Expect=1e-14]} {Dmel: FBgn0030576, CG15890, [RH, Score=100, Expect=5e-22]} {Celegans: WBGene00016705, C46C11.2, [RH, Score=95.9, Expect=6e-21]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=344, Expect=1e-113]} {RNA1509_40290} {RNA1310_13436} {RNA815_19265} |
76. | MligTC455_52629 | 472 | 9.83 | Mlig455_059435 | Neo: - Age: Down-Up-Up Region-specific R2: 6.775 Region-enriched R2: 6.727/0.00002 |
2.555 | 0.840 | - | - | 0.995 | - | 0.720 | Mlig455_059435 {REF} {Length: 726} {RNA1509_48505} {RNA1310_62885} {RNA815_39881} | |
77. | MligTC455_43095 | 294 | 6.13 | Mlig455_028880 | Neo: - Age: - Region-enriched R2: 5.606/0.00021 |
2.553 | 0.848 | - | 0.741 | 0.964 | - | - | Mlig455_028880 {REF} {Length: 822} {RNA1509_32622} {RNA1310_67920, RNA1509_32622} {RNA1509_32622, RNA815_31932.2} | |
78. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 2.549 | 0.860 | - | - | 0.982 | - | 0.707 | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
79. | MligTC455_50374 | 1072 | 22.34 | Mlig455_045630, Mlig455_045678, Mlig455_045690 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.453/0.01939 |
2.54 | 0.824 | - | 0.717 | 0.999 | - | - | Mlig455_045630 {REF} {Length: 996} {RNA1509_39842} {RNA1310_39114} {RNA815_33706.1} Mlig455_045678 {REF} {Length: 1150} {Pfam: SWR1 chromatin-remodelling complex, sub-unit Swc7 [PF17330.4, score=23.3]; DraK Histidine Kinase N-terminal domain [PF18092.3, score=20.0]} {RNA1509_39842} {RNA1310_39114} {RNA815_33706.1} Mlig455_045690 {REF} {Length: 1086} {Pfam: SWR1 chromatin-remodelling complex, sub-unit Swc7 [PF17330.4, score=20.9]} {RNA1509_39842} {RNA1310_39114, RNA1509_39842} {RNA1509_39842, RNA815_33706.1} |
|
80. | MligTC455_45912 | 1103 | 22.98 | Mlig455_006912 | Neo: - Age: - Region-specific R2: 3.366 Region-enriched R2: 1.790/0.00307 |
2.539 | 0.863 | - | - | 0.965 | 0.711 | - | Mlig455_006912 {REF} {Length: 1066} {RNA1509_32903, RNA1509_42927} {RNA1310_38334, RNA1509_42927} {RNA1509_42927, RNA815_18393} | |
81. | MligTC455_50348 | 34 | 0.7 | Mlig455_012803 | Neo: - Age: - |
2.537 | 0.823 | - | 0.725 | 0.989 | - | - | Mlig455_012803 {REF} {Length: 488} {RNA1509_48155} {RNA1310_70969.2} {RNA815_39712} | |
82. | MligTC455_50172 | 243 | 5.05 | Mlig455_067182 | Neo: - Age: Down-Up-Up Region-specific R2: 6.036 Region-enriched R2: 6.524/0.00000 |
2.527 | 0.800 | - | - | 0.970 | 0.757 | - | Mlig455_067182 {REF} {Length: 638} {Pfam: Pancreatic hormone peptide [PF00159.20, score=47.5]} {RNA1509_60030} {RNA1310_56761, RNA1509_60030} {RNA1509_60030, RNA815_31877.1} | |
83. | MligTC455_42510 | 125 | 2.6 | Mlig455_025998, Mlig455_070424 | Neo: - |
2.522 | 0.856 | - | - | 0.953 | - | 0.713 | Mlig455_025998 {REF} {Length: 1369} {RNA1310_73875.1} Mlig455_070424 {REF} {Length: 1082} {RNA1310_73875.1} |
|
84. | MligTC455_38682 | 102 | 2.12 | Mlig455_039641 | Neo: - Age: - Region-enriched R2: 6.138/0.02363 |
SLC18A3 | 2.516 | 0.990 | - | - | 0.805 | 0.721 | - | Mlig455_039641 {REF} {Length: 3925} {Pfam: Major Facilitator Superfamily [PF07690.18, score=147.1]; Sugar (and other) transporter [PF00083.26, score=29.0]; LacY proton/sugar symporter [PF01306.21, score=20.2]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [RH, Score=469, Expect=9e-161]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [RH, Score=469, Expect=1e-160]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [RH, Score=513, Expect=2e-177]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [RH, Score=486, Expect=2e-167]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [RH, Score=563, Expect=0.0]} {RNA1310_28397} {RNA815_32284.1} |
85. | MligTC455_35895 | 102 | 2.12 | Mlig455_063971 | Neo: - Age: - |
RYK | 2.514 | 0.962 | - | - | 0.709 | 0.843 | - | Mlig455_063971 {REF} {Length: 3496} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=209.4]; WIF domain [PF02019.20, score=109.7]; Protein kinase domain [PF00069.27, score=79.1]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=202, Expect=1e-55]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [RH, Score=202, Expect=2e-55]} {Dmel: FBgn0015380, drl, derailed, [RH, Score=239, Expect=4e-69]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [Score=179, Expect=6e-48]} {Smed: dd_Smed_v6_12594_0_2, dd_Smed_v6_12594_0_2, [Score=201, Expect=3e-55]} {RNA1509_58811} {RNA1310_6671.2} {RNA815_41921} |
86. | MligTC455_40444 | 2996 | 62.42 | Mlig455_039527, Mlig455_051318 | Neo: - Age: Down-Up-Down |
2.51 | 0.799 | - | - | 0.985 | 0.726 | - | Mlig455_039527 {REF} {Length: 710} {RNA1509_7655} {RNA1310_63393} {RNA815_30324} Mlig455_051318 {REF} {Length: 721} {RNA1509_7655} {RNA1310_63393, RNA1509_7655} {RNA1509_7655, RNA815_30324} |
|
87. | MligTC455_31933 | 105 | 2.18 | Mlig455_062083 | Neo: - Age: - |
ANGPTL1 | 2.5 | 0.991 | - | - | 0.753 | 0.756 | - | Mlig455_062083 {REF} {Length: 1024} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=156.7]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=135, Expect=7e-36]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=132, Expect=2e-34]; ENSG00000101280, ANGPT4, angiopoietin 4, [Score=132, Expect=9e-35]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=137, Expect=1e-36]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=132, Expect=4e-35]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=131, Expect=1e-34]} {Dmel: FBgn0034160, CG5550, [Score=130, Expect=2e-36]} {Celegans: WBGene00020516, T15B7.1, [Score=73.9, Expect=9e-15]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=126, Expect=2e-32]} {RNA1509_14033} {RNA1310_32107.2} {RNA815_17173.3} |
88. | MligTC455_48935 | 27 | 0.57 | Mlig455_041669 | Neo: - Age: - |
2.497 | - | - | 0.792 | 0.989 | 0.716 | - | Mlig455_041669 {REF} {Length: 1052} {Smed: dd_Smed_v6_3795_0_1, dd_Smed_v6_3795_0_1, [Score=56.2, Expect=8e-10]} {RNA1310_58309} {RNA815_39074} | |
89. | MligTC455_39064 | 110 | 2.28 | Mlig455_000222, Mlig455_058480 | Neo: Irradiation Age: - Region-enriched R2: 5.418/0.00017 |
OSBPL1A | 2.495 | 0.834 | - | - | 0.956 | 0.705 | - | Mlig455_000222 {REF} {Length: 2113} {Pfam: Oxysterol-binding protein [PF01237.20, score=414.5]} {Human: ENSG00000141447, OSBPL1A, oxysterol binding protein like 1A, [RH, Score=375, Expect=2e-116]; ENSG00000130703, OSBPL2, oxysterol binding protein like 2, [RH, Score=357, Expect=8e-115]} {Mouse: ENSMUSG00000044252, Osbpl1a, oxysterol binding protein-like 1A, [RH, Score=378, Expect=4e-122]; ENSMUSG00000039050, Osbpl2, oxysterol binding protein-like 2, [RH, Score=367, Expect=6e-119]} {Dmel: FBgn0034951, CG3860, [RH, Score=409, Expect=1e-135]} {Celegans: WBGene00008832, obr-2, Oxysterol Binding protein (OSBP) Related, [RH, Score=239, Expect=3e-71]} {Smed: dd_Smed_v6_3179_0_1, dd_Smed_v6_3179_0_1, [RH, Score=385, Expect=3e-126]} {RNA1509_29630} {RNA1310_38654} {RNA815_7740} Mlig455_058480 {REF} {Length: 2888} {TRANSSPLICED} {Pfam: Oxysterol-binding protein [PF01237.20, score=414.5]} {Human: ENSG00000141447, OSBPL1A, oxysterol binding protein like 1A, [RH, Score=375, Expect=2e-116]; ENSG00000130703, OSBPL2, oxysterol binding protein like 2, [RH, Score=357, Expect=8e-115]} {Mouse: ENSMUSG00000044252, Osbpl1a, oxysterol binding protein-like 1A, [RH, Score=378, Expect=4e-122]; ENSMUSG00000039050, Osbpl2, oxysterol binding protein-like 2, [RH, Score=367, Expect=6e-119]} {Dmel: FBgn0034951, CG3860, [RH, Score=409, Expect=1e-135]} {Celegans: WBGene00008832, obr-2, Oxysterol Binding protein (OSBP) Related, [RH, Score=239, Expect=3e-71]} {Smed: dd_Smed_v6_3179_0_1, dd_Smed_v6_3179_0_1, [RH, Score=385, Expect=3e-126]} {RNA1509_29630} {RNA1310_38654} {RNA815_26411} |
90. | MligTC455_19708 | 304 | 6.32 | Mlig455_009784 | Neo: - Age: - Region-enriched R2: 6.355/0.00039 |
2.491 | - | - | - | 0.991 | 0.725 | 0.775 | Mlig455_009784 {REF} {Length: 826} {Pfam: Pancreatic hormone peptide [PF00159.20, score=43.3]} {RNA1509_54211} {RNA1310_54505.1, RNA1509_54211} {RNA1509_54211, RNA815_29389} | |
91. | MligTC455_41296 | 43 | 0.9 | Mlig455_021118 | Neo: - Age: - |
2.49 | 0.799 | - | - | 0.977 | 0.714 | - | Mlig455_021118 {REF} {Length: 2049} {RNA1509_59262} {RNA1310_31928} {RNA815_32415} | |
92. | MligTC455_31345 | 102 | 2.12 | Mlig455_004435, Mlig455_004447 | Neo: - Age: - |
RTL1 | 2.489 | 0.793 | - | - | 0.988 | 0.708 | - | Mlig455_004435 {REF} {Length: 551} {RNA1310_70973} {RNA815_36768} Mlig455_004447 {REF} {Length: 2743} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=93.3]; Integrase zinc binding domain [PF17921.3, score=77.6]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=45.9]} {Human: ENSG00000254656, RTL1, retrotransposon Gag like 1, [Score=75.9, Expect=2e-13]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=255, Expect=1e-71]} {RNA1509_33330} {RNA1310_5975.2} {RNA815_11487} |
93. | MligTC455_33039 | 312 | 6.51 | Mlig455_032494 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.545/0.00267 |
PKDREJ | 2.488 | 0.970 | - | - | 0.792 | 0.726 | - | Mlig455_032494 {REF} {Length: 11952} {Pfam: Polycystin cation channel [PF08016.14, score=289.9]; REJ domain [PF02010.17, score=90.4]; PLAT/LH2 domain [PF01477.25, score=68.4]; PKD domain [PF00801.22, score=57.9]; PKD domain [PF18911.2, score=36.7]; Ion transport protein [PF00520.33, score=36.3]; GPCR proteolysis site, GPS, motif [PF01825.23, score=30.0]; WSC domain [PF01822.21, score=23.3]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=267, Expect=1e-70]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=292, Expect=3e-78]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=136, Expect=2e-31]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [RH, Score=297, Expect=4e-80]} {Smed: dd_Smed_v6_15525_0_1, dd_Smed_v6_15525_0_1, [Score=1504, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814} |
94. | MligTC455_50844 | 224 | 4.67 | Mlig455_018511 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.591/0.00005 |
SSUH2 | 2.487 | 0.962 | - | - | 0.823 | 0.702 | - | Mlig455_018511 {REF} {Length: 1843} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=120, Expect=2e-29]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=95.5, Expect=3e-21]} {RNA1509_39980} {RNA1310_60742, RNA1509_39980} {RNA1509_39980, RNA815_28938} |
95. | MligTC455_17578 | 447 | 9.32 | Mlig455_010738 | Neo: - Age: Down-Up-Up Region-specific R2: 8.320 Region-enriched R2: 9.793/0.00000 |
2.485 | 0.784 | - | - | 0.991 | - | 0.710 | Mlig455_010738 {REF} {Length: 642} {RNA1509_48297, RNA1509_55742} {RNA1310_84623, RNA1509_48297, RNA1509_55742} {RNA1509_48297, RNA1509_55742, RNA815_45356} | |
96. | MligTC455_37047 | 45 | 0.94 | Mlig455_046180 | Neo: - Age: - |
2.485 | 0.959 | - | - | 0.765 | 0.761 | - | Mlig455_046180 {REF} {Length: 1686} {RNA1310_140241} {RNA815_12716} | |
97. | MligTC455_46451 | 229 | 4.76 | Mlig455_017183 | Neo: - Age: Down-Up-Down Region-specific R2: 5.510 Region-enriched R2: 5.394/0.00018 Regeneration-downregulated R2: -2.986 Regeneration-depleted R2: -2.986 |
2.485 | 0.791 | - | - | 0.987 | - | 0.707 | Mlig455_017183 {REF} {Length: 657} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.6]} {RNA1310_62963} {RNA815_31352} | |
98. | MligTC455_18834 | 33 | 0.68 | Mlig455_000603 | Neo: - Age: - |
2.484 | 0.774 | - | - | 0.990 | - | 0.720 | Mlig455_000603 {REF} {Length: 1888} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_27913} {RNA815_25050} | |
99. | MligTC455_48756 | 622 | 12.96 | Mlig455_054772, Mlig455_054799, Mlig455_054893 | Neo: - Age: - Region-specific R2: 7.873 Region-enriched R2: 9.003/0.00000 |
2.478 | 0.764 | - | - | 0.996 | - | 0.718 | Mlig455_054772 {REF} {Length: 716} {RNA1509_41507} {RNA1310_49516} {RNA815_28703} Mlig455_054799 {REF} {Length: 625} {RNA1509_41507} {RNA1310_49516} {RNA815_28703} Mlig455_054893 {REF} {Length: 947} {RNA1509_41507} {RNA1310_49516, RNA1509_41507} {RNA1509_41507, RNA815_28703} |
|
100. | MligTC455_21182 | 238 | 4.96 | Mlig455_000068, Mlig455_063733 | Neo: - Age: Down-Up-Up Region-enriched R4: 5.301/0.04587 |
2.476 | 0.963 | - | 0.704 | 0.809 | - | - | Mlig455_000068 {REF} {Length: 468} {Pfam: Pancreatic hormone peptide [PF00159.20, score=23.7]} {RNA1310_81800.1} {RNA815_55075} Mlig455_063733 {REF} {Length: 531} {Pfam: Pancreatic hormone peptide [PF00159.20, score=20.7]} {RNA1310_81800.1} {RNA815_55075} |